Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Harneet Walia, MD, FAASM is an Assistant Professor in the Clinic Lerner College of Medicine of Case Western Reserve University (CCLCM) where she subspecializes in diagnoses and treatment of complex sleep disorders. She is a Staff at the Center for Sleep Disorders in the Neurological Institute, Cleveland Clinic. She is board-certified by the American Board of Family Medicine and has additional board certification in Sleep Medicine.
Dr. Walia received her MD degree from the Kasturba Medical College, India. She completed her residency at St. Elizabeth Health Center and fellowship training at the University Hospitals of Cleveland, Case Western Reserve University.
Dr. Walia's research focuses on the association of obstructive sleep apnea and cardiovascular disorders particularly resistant hypertension. She is currently involved in several clinical trials elucidating the relationship between sleep disordered breathing and resistant hypertension to devise new interventions for effective management of hypertension in this patient population. Her results have been presented nationally and have resulted in over 40 abstracts, manuscripts and book chapters.
Dr. Walia has given numerous presentations on the topics related to sleep disorders.
She is involved in media relations to increase awareness of sleep disorders and has appeared on numerous national news broadcasts. She mentors sleep medicine fellows and serves as reviewer on multiple journals including Sleep and Breathing, American Family Physician, Journal of Clinical Sleep Medicine and Journal of Clinical Sleep Research
Dr. Walia has been recipient of research awards including sleep research travel award and was selected from the competitive pool of applicants to attend Young Investigator Forum in 2012 by American Academy of Sleep Medicine. She was selected to attend FLEX Professional Development Program for Women Faculty of the School of Medicine. She was also chosen for the Neurological Institute Center for Outcomes Research and Evaluation scholar award. She has been selected for Women's Professional Staff Association Senior Rep Program.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/27/2015, Dr. Walia has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.